CAMBRIDGE, Mass.

Vaxess Technologies, Inc., an innovative life sciences company developing novel stabilization and delivery technologies, was awarded highly competitive supplemental funding in the context of the Small Business Innovation Research (SBIR) program from the National Science Foundation (NSF). Funding totaling $650,000 will go toward the further advancement of MIMIXTM, a novel sustained-release vaccine delivery system enabling more effective, shelf-stable vaccines.

NSF funding was awarded following the successful achievement of SBIR phase II milestones, including the development of a broadly protective, sustained-release influenza vaccine on the MIMIXTM platform, which is now advancing to pre-clinical development. The additional funding will support the advancement of follow-on products on the MIMIXTM platform, including mRNA vaccines.

“Building on the success of the Phase II program, we will continue the development of highly effective vaccines with our novel sustained release MIMIX platform to improve global vaccine coverage,” said Vaxess Vice President of Policy and Strategy Livio Valenti. “NSF funds are critical for the advancement of the MIMIX sustained release platform and its extension to several additional high-potential vaccine targets.”

About Vaxess Technologies
Vaxess Technologies is advancing several vaccine targets toward clinical development using its proprietary MIMIXTM sustained release platform. Vaxess has combined venture capital funding with grants and pharmaceutical partnerships to build a pipeline of vaccines and other products that are more effective and distributed without refrigeration.

For more information please visit the company website at http://www.vaxess.com or send additional inquiries to contact(at)vaxess.com.

About the National Science Foundation's Small Business Programs
America’s Seed Fund powered by the National Science Foundation (NSF) awards nearly $200 million annually to startups and small businesses, transforming scientific discovery into products and services with commercial and societal impact. Startups working across almost all areas of science and technology can receive up to $1.5 million in non-dilutive funds to support research and development (R&D), helping de-risk technology for commercial success. America’s Seed Fund is congressionally mandated through the Small Business Innovation Research (SBIR) program. The NSF is an independent federal agency with a budget of about $7.5 billion that supports fundamental research and education across all fields of science and engineering. To learn more about the NSF SBIR/STTR program, visit: seedfund.nsf.gov.

Powered by WPeMatico